RLAY
Price
$8.07
Change
+$0.13 (+1.64%)
Updated
Jan 14 closing price
Capitalization
1.4B
35 days until earnings call
Intraday BUY SELL Signals
XNCR
Price
$14.45
Change
+$0.51 (+3.66%)
Updated
Jan 14 closing price
Capitalization
1.03B
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RLAY vs XNCR

Header iconRLAY vs XNCR Comparison
Open Charts RLAY vs XNCRBanner chart's image
Relay Therapeutics
Price$8.07
Change+$0.13 (+1.64%)
Volume$1.15M
Capitalization1.4B
Xencor
Price$14.45
Change+$0.51 (+3.66%)
Volume$560.22K
Capitalization1.03B
RLAY vs XNCR Comparison Chart in %
View a ticker or compare two or three
VS
RLAY vs. XNCR commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (RLAY: $8.07 vs. XNCR: $14.45)
Brand notoriety: RLAY and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 54% vs. XNCR: 70%
Market capitalization -- RLAY: $1.4B vs. XNCR: $1.03B
RLAY [@Biotechnology] is valued at $1.4B. XNCR’s [@Biotechnology] market capitalization is $1.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 4 bearish.
  • XNCR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than XNCR.

Price Growth

RLAY (@Biotechnology) experienced а -1.34% price change this week, while XNCR (@Biotechnology) price change was -3.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

RLAY is expected to report earnings on Feb 19, 2026.

XNCR is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($1.4B) has a higher market cap than XNCR($1.03B). RLAY YTD gains are higher at: -4.610 vs. XNCR (-5.617). XNCR has higher annual earnings (EBITDA): -85.79M vs. RLAY (-322.8M). RLAY has more cash in the bank: 596M vs. XNCR (471M). RLAY has less debt than XNCR: RLAY (33.3M) vs XNCR (69.3M). XNCR has higher revenues than RLAY: XNCR (150M) vs RLAY (8.36M).
RLAYXNCRRLAY / XNCR
Capitalization1.4B1.03B135%
EBITDA-322.8M-85.79M376%
Gain YTD-4.610-5.61782%
P/E RatioN/AN/A-
Revenue8.36M150M6%
Total Cash596M471M127%
Total Debt33.3M69.3M48%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYXNCR
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
64%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
RLAY
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FREAX14.480.10
+0.70%
Nuveen Real Estate Securities A
MEMGX44.260.19
+0.43%
MFS Emerging Markets Equity R3
RDWEX14.590.04
+0.27%
American Funds Dvlpg Wld Gr&Inc R4
GMEPX29.230.02
+0.07%
Goldman Sachs China Equity P
MSPRX24.04-0.34
-1.39%
Morgan Stanley Inst Advantage C

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with NRIX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+1.64%
NRIX - RLAY
52%
Loosely correlated
+0.58%
VIR - RLAY
52%
Loosely correlated
+8.08%
KURA - RLAY
51%
Loosely correlated
+1.63%
IMNM - RLAY
51%
Loosely correlated
+3.08%
BEAM - RLAY
50%
Loosely correlated
+2.49%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with NUVL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+3.66%
NUVL - XNCR
60%
Loosely correlated
+6.59%
KURA - XNCR
59%
Loosely correlated
+1.63%
CRNX - XNCR
59%
Loosely correlated
+2.04%
IDYA - XNCR
58%
Loosely correlated
+5.53%
SYRE - XNCR
57%
Loosely correlated
+5.17%
More